ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
Oct 7, 2026, 4:10 PM AEST
ImpediMed Market Cap
ImpediMed has a market cap or net worth of 21.97 million as of October 7, 2026. That makes ImpediMed the world's 39,020th most valuable company and 1,072nd in Australia. Its market cap has decreased by 78.42% in one year.
Market Cap
21.97M
Enterprise Value
23.28M
Revenue
14.61M
Global Rank
Country Rank
#1,072 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since October 24, 2007, ImpediMed's market cap has decreased from 67.49M to 21.97M, a decrease of -67.44%. That is a compound annual growth rate of -5.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 21.97M | -68.29% |
| Dec 31, 2025 | 69.30M | -34.16% |
| Dec 31, 2024 | 105.26M | -64.12% |
| Dec 29, 2023 | 293.38M | 108.23% |
| Dec 30, 2022 | 140.90M | -54.66% |
| Dec 31, 2021 | 310.77M | 130.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 49.82M |
| Cleo Diagnostics | 45.93M |
| Micro-X | 40.63M |
| CleanSpace Holdings | 39.68M |
| Nova Eye Medical | 38.46M |
| Control Bionics | 35.30M |
| OncoSil Medical | 26.24M |
| CurveBeam AI | 16.90M |